Quorum Information Technologies Receives Shareholder Support for Proposed Arrangement and Announces Final Order Approving Arrangement
CALGARY, Alberta, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc.…
MainStreaming Named in the 2025 Gartner Market Guide for Edge Distribution Platforms
MILAN, Nov. 26, 2025 /PRNewswire/ -- MainStreaming, the award-winning and innovative Edge…
NEW GSMA REPORT WARNS THAT FRAGMENTED CYBERSECURITY REGULATION IS RAISING COSTS AND INCREASING RISK FOR MOBILE OPERATORS
The mobile industry, supported by the GSMA, calls for harmonised, risk-based and…
Bahrain Lowers Minimum Real Estate Investment for Golden Residency to USD 345,000
MANAMA, Bahrain, Nov. 26, 2025 /PRNewswire/ -- In a move aimed at…
New micromobility concepts for increased sustainability in urban traffic: BMW Group grants licenses to the LUYUAN Group
HANGZHOU, China, Nov. 26, 2025 /PRNewswire/ -- The BMW Group has officially…
Singapore no. 1 in global competition for talent
FONTAINEBLEAU, France and SINGAPORE and SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ --…
PAVING THE WAY FOR WOMEN’S VOICES: ENTREPRENEUR SHAILI CHOPRA SHARES HER ADVICE FOR FEMALE FOUNDERS ON THE FOUNDERMETRICS PODCAST, BY VESTD
FROM BUSINESS REPORTER TO FOUNDING A WOMEN'S MOVEMENT: SHAILI CHOPRA'S JOURNEY TO…
CreditNirvana Launches ‘Maestro’, a Debt Collection AI Agentic Platform for End-to-End Recoveries
Reduces human intervention by 60–70%Boosts collection efficiency by 40%+ through multilingual GenAI…
Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia
November 25, 2025 18:15 ET | Source: Ascendis Pharma – Prescription Drug…
KOMZIFTI (ziftomenib) Added to National Comprehensive Cancer Network (NCCN) Guidelines for Acute Myeloid Leukemia (AML)
KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated…
